Advanced Breast Biopsy Instrumentation
Links shared publicly online about this topic
iCAD, Hitachi enter distribution agreement for MRI breast cancer diagnosis and guided biopsy solution
news-medical.net — “iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that it has entered into a distribution agreement with Hitachi Medical Systems.” View full resource at news-medical.net
Most Recently Shared on October 31, 2011 at 7:09 pm By:
Breast Cancer News: iCAD, Hitachi enter distribution agreement for MRI breast cancer diagnosis and guided biopsy... http://t.co/Lg5qd2EJ
International Scientific Cooperation to Advance Image-Guided Prostate Cancer Care
acr.org — “To improve early diagnosis and treatment of prostate cancer, ACR, AdMeTech Foundation and ESUR have formed a joint effort to expedite development of standards for the Magnetic Resonance Prostate Imaging Reporting and Data System (MR PI-RADS) modeled after a successful effort in breast cancer care. The goal is to expedite the transfer of high-quality MRI from laboratories to patients to address the major need in prostate cancer care — reducing unnecessary biopsies and treatment.” View full resource at acr.org
Most Recently Shared on February 7, 2012 at 5:00 pm By:
International Scientific Cooperation to Advance Image-Guided Prostate Cancer Care http://t.co/i2bSPA2R #imaging #prostatecancer
REFILE-UPDATE 2-Novartis gets good news on cancer drug Afinitor | Reuters
uk.reuters.com — “(Corrects Reuters instrument code in first paragraph) * Novartis drug helps with advanced breast cancer * Trial stopped early after positive interim results * Regulatory filings expected later” View full resource at uk.reuters.com
Most Recently Shared on July 5, 2011 at 11:17 am By:
John Carroll Health Communicator
Novartis halts Afinitor breast cancer study on positive data; preps new app for blockbuster market. http://reut.rs/lIXcLd
Next: Cancer software - Oregon Business
oregonbusiness.com — “MRIs have been a longstanding alternative to using painful and invasive biopsies to diagnose breast cancer. But MRIs accurately distinguish malignant from benign breast cancer tumors only 30% of the time. Charles Springer, a senior scientist at the Advanced Imaging Research Center at Oregon Health & Science University, five years ago began developing MRI software that looked past the image's brightness to analyze how fast dye traveled out of the tumor cells.” View full resource at oregonbusiness.com
Most Recently Shared on August 18, 2010 at 6:09 pm By:
OHSU Healthcare Healthcare System
135 patients, 100% accuracy. So cool. RT @OregonBusiness: Scientist at @OHSUHealthcare improves cancer testing accuracy http://bit.ly/91TllD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest breast cancer news and research via News-Medical.Net
-
ACR Radiology
Official Twitter account for the American College of Radiology. The ACR is committed to making imaging safe, effective and accessible to those who need it.
-
John Carroll
John Carroll is editor of FierceBiotech, where he primarily covers drug development and has for the past eight years.
Advertisement
